Hongbing He

570 citations
21 papers · 462 indexed · h-index 11
Topics
Oral microbiology and periodontitis research (8 papers)MicroRNA in disease regulation (4 papers)Immune Response and Inflammation (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Hongbing He

20 papers receiving 456 citations

Peers

Hongbing He
Comparison fields: 5 of 80
  • Molecular Biology 207
  • Periodontics 139
  • Cancer Research 77
  • Immunology 62
  • Oncology 50
Replace Yuta Katsumata with:
Yuta Katsumata Japan
Isamu Kodani Japan
Juliete A.F. Silva Brazil
Pengfei Zhao China
Lulingxiao Nie China
Yuji Inagaki Japan
Satoru Shindo Japan
Yasunori Yoshinaga Japan
Daijiro Hatakeyama Japan
Stephanie Zwicker Sweden
Hongbing He relative to Yuta Katsumata Japan Yuta Katsumata's profile →
Citations per field
00.5×10×14×
Yuta Katsumata · 1×
Citations per year

Countries citing papers authored by Hongbing He

Since Specialization
Citations

This map shows the geographic impact of Hongbing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing He more than expected).

Fields of papers citing papers by Hongbing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing He. The network helps show where Hongbing He may publish in the future.

Co-authorship network of co-authors of Hongbing He

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbing He. A scholar is included among the top collaborators of Hongbing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbing He. Hongbing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 4
4 4
5 4
6 6
7 1
8 10
9 21
10 40
11 22
12 15
13 10
14 24
15 9
16 28
17
[Osteoblast apoptosis in experimental diabetic periodontitis in rats].
2
18 56
19 153
20 49

About Hongbing He

Hongbing He is a scholar working on Periodontics, Pharmacy and Cancer Research, having authored 21 papers that have together received 462 indexed citations. Recurring topics across this work include Oral microbiology and periodontitis research (8 papers), MicroRNA in disease regulation (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Periodontics (139 citations), Cancer Research (77 citations) and Orthopedics and Sports Medicine (44 citations). Hongbing He has collaborated with scholars based in China and United States. Frequent co-authors include Rongkun Liu, Dana T. Graves, Tesfahun Desta, Cataldo Leone, Louis C. Gerstenfeld, Yong‐Wei Fu, Xiaobin Ren, Mani Alikhani, Yu Shi and Xianbo Jia. Their work appears in journals such as Journal of Biological Chemistry, Endocrinology and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026